Wikipedia -WSS

Wikipedia

author：knowledge 2025-09-29 19:58:50 - browse：6239

A follow-up study of a first-of-its-kind cancer treatment may reflect systemic biases, the Food and Drug Administration said ahead of an advisory committee meeting Thursday to determine whether the drug should remain on the market.

The treatment, Lumakras, is designed to treat lung cancer caused by a specific genetic mutation to a protein called KRAS. It’s one of the most common genetic mutations in cancer, but repeated clinical trial failures had led researchers to deem it “undruggable” until a glimmer of hope came about a decade ago.

Lumakras received an accelerated, or conditional, approval in May 2021, making it the first KRAS drug on the market. Now, the drug’s manufacturer, Amgen, needs to prove it works.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Duchenne breakthrough therapy leaves behind pioneering families
Next article： Sanofi CEO defends move to abandon profit guidance, boost research

WSS

Biotech incubator Curie.Bio graduates its first startup

Data integrity in scientific journals requires "effort" by publishers, institutions

It's time to retire 'poor historian' from clinicians' vocabularies

Medicare solvency divides Republicans at the presidential debate

Free speech concerns arise in wake of journal editor Eisen's firing

The Readout: Lisata, Eisai x Biogen, and the Met Gala (!)

Wikipedia

Wikipedia

focus

Continuity nursing helped my family in our darkest PICU moments

STAT Executive Editor Rick Berke on STAT's 8th birthday

Medicare proposal to cover medical devices draws a mixed reaction

Sanofi CEO defends move to abandon profit guidance, boost research

Guidelines to prevent youth baseball injuries need more muscle

Big Tobacco's 'harm reduction': Is it for real, or a sham?

Guidelines to prevent youth baseball injuries need more muscle

Will General Catalyst be the first of many hospital takeovers?

Apple is now the first public company to be valued at $3 trillion

Biotech incubator Curie.Bio graduates its first startup

leisure time

Free speech concerns arise in wake of journal editor Eisen's firing

Extreme heat events are a public health emergency

Analysis of pharma R&D ranks Novo Nordisk, J&J above their peers

HPV cancer vaccine study demonstrates efficacy

Readout Newsletter: Nvidia, Biogen, Ionis, AstraZeneca, ChatGPT

Study: New antibiotic targets gonorrhea as well as last existing drug

Wikipedia

Wikipedia

leisure time

hotspot